Tirzepatide 40mg (Research and development only) / TIRTERUI

Tirzepatide 40mg pre filled research formulation – high-purity synthetic dual receptor agonist is produced using a validated solid-phase synthesis process and strict GMP quality control. The purity is ≥ 98% (typical batch>99%) analyzed by RP-HPLC, and the molecular weight and sequence integrity are confirmed by high-resolution LC-MS to ensure high consistency and long-term stability between batches. Delivered in the form of sealed pre installed research pens, with a fixed capacity design to reduce manual preparation errors, supporting precise in vitro/cellular level compound stability testing, formulation development, and delivery system evaluation (such as permeability and release kinetics studies). Each research kit includes:

1 pre installed research pen (40mg Tirzepatide, high-purity synthetic peptide)
Detailed Research Information Table (Aluvi Healthcare, providing physical and chemical parameters, recommended laboratory operation guidelines, and example COA references)

Storage conditions:
Unopened products should be refrigerated and stored at 2-8 ° C to avoid freezing and maintain molecular integrity. Suggest using under recommended conditions to ensure data reliability. Important research statement:
For laboratory research purposes only. This product is not suitable for any non research purposes. All operations must comply with the Institutional Review Board (IRB) and local laws and regulations. We provide transparent analytical data support for the research team (HPLC chromatograms, MS spectra, and COA can be provided as needed). ‍